Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed the MHRA that some packs from a batch of zoledronic acid 5mg solution for infusion contain a patient information leaflet for temozolomide 180mg capsules.
Further information, affected batch details and advice for healthcare professionals can be found on the MHRA website.